Skip to main content
. 2023 Apr 17;9(4):e15545. doi: 10.1016/j.heliyon.2023.e15545

Fig. 7.

Fig. 7

The MD simulations timelines for the EGFR systems uncomplexed, and complexed with the ligands C11, T15, Tamoxifen, and Erlotinib. (a) RMSD of C-alpha backbones of EGFR systems, (b) RMSF of side chains of EGFR systems, (c) RMSF of ligands complexed with EGFR.